Recent Advances in Plant-Based Drug Discovery: From Phytochemicals to Modern Therapeutics-A Review

Authors

  • Vamshi Sharathnath Kaveti Associate Professor, Department of Pharmacognosy, Nalla Narasimha Reddy Education Society’s Group of Institutions, School of Pharmacy, Chowdariguda, Ghatkesar, Medchal, Hyderabad, Telangana, India – 500 088.

Keywords:

Medicinal plants, Phytochemicals, Natural products, Drug discovery, Phytopharmaceuticals, Plant-derived therapeutics

Abstract

Plants have served as an important source of therapeutic agents for centuries and continue to provide structurally diverse molecules with significant pharmaceutical potential. Plant-derived secondary metabolites, including alkaloids, flavonoids, terpenoids, phenolic compounds, glycosides, saponins, tannins, steroids and lignans, possess a wide range of biological activities and have contributed to the development of modern medicines. Recent advances in analytical chemistry, metabolomics, genomics, molecular biology, computational drug discovery, artificial intelligence, network pharmacology and synthetic biology have significantly changed the process of identifying and developing therapeutically valuable compounds from medicinal plants. Modern plant-based drug discovery increasingly combines traditional medicinal knowledge with scientific validation, high-throughput screening, chromatographic and spectroscopic characterization, molecular target identification and computational prediction. Natural-product databases and computer-aided drug discovery approaches can facilitate virtual screening, molecular interaction analysis, structure modification and prediction of pharmacokinetic properties. Advances in plant biosynthetic pathway elucidation and metabolic engineering are also creating new possibilities for producing valuable natural products that occur in very low concentrations in their original plant sources. Plant-derived anticancer compounds, antimicrobial agents, anti-inflammatory molecules, cardiovascular therapeutics and compounds targeting metabolic and neurological disorders continue to receive considerable research attention. However, challenges such as variation in plant material, low yield, complex chemical composition, poor solubility, limited bioavailability, toxicity, difficulties in standardization and inconsistent clinical evidence can restrict translation from traditional use to modern therapeutics. Phytopharmaceutical development therefore requires rigorous botanical authentication, phytochemical standardization, pharmacological evaluation, toxicological assessment, quality control and appropriate clinical investigation. This review discusses recent advances in plant-based drug discovery, emphasizing phytochemicals, modern screening technologies, computational approaches, biosynthetic engineering, phytopharmaceutical development, therapeutic applications, challenges and future perspectives.

Downloads

Download data is not yet available.

Published

2026-10-01

How to Cite

Kaveti, V. S. (2026). Recent Advances in Plant-Based Drug Discovery: From Phytochemicals to Modern Therapeutics-A Review. MedPharm Insights, 1(1). Retrieved from https://cognixpress.in/index.php/mpi/article/view/85